Relationship between FOXP3 positive populations and cytokine production in systemic lupus erythematosus

Cytokine

Volumn 61, Issue 1, 2013, Pages 90-96

  Prado, Catuxa ^a   de Paz, Banesa ^a   López, Patricia ^a   Gómez, Jesús ^b   Rodríguez Carrio, Javier ^a   Suárez, Ana ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

FOXP3; IL 17A; SLE; Treg

Indexed keywords

CD24 ANTIGEN; CD4 ANTIGEN; CD45RO ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 6; INTERLEUKIN 7 RECEPTOR; INTERLEUKIN 8; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ACTIVITY; DISEASE DURATION; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE SUBPOPULATION; UPREGULATION;

CD4-POSITIVE T-LYMPHOCYTES; CELL TRANSDIFFERENTIATION; CYTOKINES; DISEASE PROGRESSION; DOWN-REGULATION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERLEUKIN-17; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; UP-REGULATION;

EID: 84869870361     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.08.033     Document Type: Article

References (36)

1. Sakaguchi S., Sakaguchi N., Asano M., et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995, 155:1151-1164.
2. Gerli R., Nocentini G., Alunno A., et al. Identification of regulatory T cells in systemic lupus erythematosus. Autoimmun Rev 2009, 8:426-430.
3. + regulatory T cells. Nat Immunol 2003, 4:330-336.
4. Buckner J.H., Ziegler S.F. Regulating the immune system: the induction of regulatory T cells in the periphery. Arthritis Res Ther 2004, 6:215-222.
5. + T cells. Eur J Immunol 2007, 37:129-138.
6. + T cells of patients with systemic lupus erythematosus: a comparative phenotypic analysis. Ann Rheum Dis 2008, 67:664-671.
7. Lin S., Chen K., Lin C., et al. The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients. Eur J Clin Invest 2007, 37:987-996.
8. +) regulatory T-cell subpopulations in systemic lupus erythematosus. Immunology 2009, 127:196-205.
9. + T cells in patients with new-onset systemic lupus erythematosus. Ann Rheum Dis 2008, 67:1037-1040.
10. highFoxp3 pos regulatory T cells differentiate into IL-17-producing cells. Blood 2008, 112:2340-2352.
11. Beriou G., Costantino C.M., Ashley C.W., et al. IL-17-producing human peripheral regulatory T cells retain suppressive function. Blood 2009, 113:4240-4249.
12. + Treg in the presence of lineage-specific polarizing factors. P Natl Acad Sci USA 2010, 107:19402-19407.
13. Annunziato F., Cosmi L., Liotta F., et al. The phenotype of human Th17 cells and their precursors, the cytokines that mediate their differentiation and the role of Th17 cells in inflammation. Int Immunol 2008, 20:1361-1368.
14. Vanaudenaerde B.M., Wuyts W.A., Dupont L.J., et al. Interleukin-17 stimulates release of interleukin-8 by human airway smooth muscle cells in vitro: a potential role for interleukin-17 and airway smooth muscle cells in bronchiolitis obliterans syndrome. J Heart Lung Transpl 2003, 22:1280-1283.
15. El-Behi M., Ciric B., Dai H., et al. The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat Immunol 2011, 12:568-575.
16. + regulatory T cell and immune tolerance. Autoimmunity 2006, 39:269-276.
17. López P., Mozo L., Gutiérrez C., et al. Epidemiology of systemic lupus erythematosus in a northern Spanish population: gender and age influence on immunological features. Lupus 2003, 12:860-865.
18. Gómez J., Suárez A., López P., et al. Systemic lupus erythematosus in Asturias, Spain: clinical and serologic features. Medicine (Baltimore) 2006, 85:157-168.
19. + T cells in patients with systemic lupus erythematosus. J Immunol 2009, 182:1689-1695.
20. Prado C., Gómez J., López P., et al. Dexamethasone upregulates FOXP3 expression without increasing regulatory activity. Immunobiology 2011, 216:386-392.
21. Wang H., Xu J., Ji X., et al. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus. Cell Immunol 2005, 235:117-121.
22. Habib H.M., Taher T.E., Isenberg D.A., et al. Enhanced propensity of T lymphocytes in patients with systemic lupus erythematosus to apoptosis in the presence of tumour necrosis factor alpha. Scand J Rheumatol 2009, 38:112-120.
23. high T regulatory cell function in patients with active systemic lupus erythematosus. J Immunol 2007, 178:2579-2588.
24. + T cells in patients with systemic lupus erythematosus. Clin Immunol 2009, 132:385-392.
25. Miyara M., Amoura Z., Parizot C., et al. Global natural regulatory T cell depletion in active systemic lupus erythematosus. J Immunol 2005, 175:8392-8400.
26. + cells in untreated new-onset lupus patients regulatory T cells?. Arthritis Res Ther 2009, 11:R153.
27. Dolff S., Bijl M., Huitema M.G., et al. Disturbed Th1, Th2, Th17 and T(reg) balance in patients with systemic lupus erythematosus. Clin Immunol 2011, 141:197-204.
28. Chen X.Q., Yu Y., Deng H.H., et al. Plasma IL-17A is increased in new-onset SLE patients and associated with disease activity. J Clin Immunol 2010, 30:221-225.
29. Shah K., Lee W., Lee S., et al. Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus. Arthritis Res Ther 2010, 12:R53.
30. Prado C., de Paz B., Gómez J., et al. Glucocorticoids enhance Th17/Th1 imbalance and signal transducer and activator of transcription three expression in systemic lupus erythematosus patients. Rheumatology (Oxford) 2011, 50:1794-1801.
31. Yang J., Chu Y., Yang X., et al. Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. Arthritis Rheum 2009, 60:1472-1483.
32. + Treg cells decrease in patients with lupus nephritis. Rheumatol Int 2012, 32:949-958.
33. +CD25 T cells. J Immunol 2007, 179:2041-2045.
34. + regulatory T cells induced by IL-2 and TGF-beta are resistant to Th17 conversion by IL-6. J Immunol 2008, 180:7112-7116.
35. - T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-β. J Immunol 2007, 178:6725-6729.
36. Bettelli E., Carrier Y., Gao W., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238.